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16S rRNA Gene Sequencing and the Routine Clinical Microbiology Laboratory:
a Perfect Marriage?
In the December 2005 issue of the Journal of Clinical Microbi-
ology, Petti et al. reported three cases of endocarditis in which 16S
rRNA gene sequencing revealed phenotypic misidentification of
the bacterial isolates (10). The authors argued in favor of imple-
mentation of 16S rRNA gene sequencing in the clinical labora-
tory, stating that this genotypic method is more objective, accu-
rate, and reliable than phenotypic methods. Regarding potential
flaws, they mentioned only that 16S rRNA gene sequencing is not
a perfect method. On the other hand, they clearly listed the many
drawbacks of phenotypic methods. Although we do not argue
against 16S rRNA gene sequencing, we believe that the opinion
of the authors is too optimistic and does not always reflect the
daily practice in a routine clinical microbiological laboratory.
Drawbacks and pitfalls of 16S rRNA gene sequencing are well-
known and have been reviewed elsewhere (6, 9). However, there
has been less attention to the obstacles towards 16S rRNA gene
sequencing from the routine clinical microbiology laboratory’s
perspective. From our daily experiences with 16S rRNA gene
sequencing, we want to comment on what we believe to be the
major problems regarding the implementation of 16S rRNA gene
sequencing in routine practice.
First, in this era of managed care in which clinical microbio-
logical laboratories are obliged to contain costs, the cost of 16S
rRNA gene sequencing remains a major obstacle. The laboratory
can save costs by purchasing directly from providers of generic
primer synthesis, general molecular reagents, and sequencing ser-
vices, since they operate at a competitive market. In contrast, the
cost to gain access to commercial databases for 16S rRNA gene
sequencing remains high and hampers its implementation in a
routine clinical microbiology laboratory. To make analysis of
sequencing data affordable, use of public databases such as
GenBank is an alternative. This brings us to the second problem:
the deposited sequences in the public databases are not peer
reviewed. Since anyone can deposit and name sequence data, the
quality of entries in GenBank is compromised by sequencing
errors and ambiguities, incomplete sequences, and insufficient
strain characterization (6, 9). On the other hand, the quality of
commercial databases is also not optimal (4, 5). This is more
related to the limited number of strains in the databases rather
than incorrect sequence entries. Third, although sequence data
are objective in nature, the interpretation of these data to estab-
lish a species designation is not. There are no universally accepted
criteria for 16S rRNA gene sequence-based identification of bac-
terial isolates. The level of sequence homology required between
the isolate under investigation and those in the databases to
conclude on genus and species designation is a matter of debate
(3). This introduces a level of subjectivity in sequence-based spe-
cies identification and, as a consequence, potential inaccuracies in
the routine laboratory setting.
In our laboratory, sequencing is used primarily as an adjunct
to phenotypic methods for the identification of difficult-to-
identify or rarely encountered bacteria. We analyze an ampli-
con of around 900 bp of the 16S rRNA gene, using primers as
described by Weisburg et al. (12). For identification of strep-
tococci, we also amplify the 16S-23S intergenic spacer region,
as described by Chen et al. (1). We analyze our sequences for
species identification by using the GenBank database and the
BLAST algorithm with default parameters. For designation to
the species or genus level, we use the identification criteria
formulated by Drancourt et al. (6) as a guideline. The genotypic
results are interpreted together with the phenotypic results and
clinical information to decide on the identification. It is our ex-
perience and that of others that the use of a public database as
described above provides reliable identifications in the vast ma-
jority of cases (2, 7, 8). So, if cost is an issue for the laboratory,
GenBank is a true alternative to commercial databases. Never-
theless, species identification is not always possible in this context.
It is our experience that the frequency of problematic identifica-
tions using GenBank has been increasing over the last few years,
especially due to the increase of sequence entries of ill-character-
ized organisms. If this trend is to continue, the usefulness of the
GenBank database will be compromised further. We illustrate
these issues with some of the problems we have recently experi-
enced in our routine laboratory.
In the previous year, we have performed 16S rRNA gene
sequence analysis on 285 bacterial isolates of 226 patients. The
identified bacteria constitute a wide range of mostly commonly
encountered bacteria but also rare ones, e.g., Actinobaculum
schaalii (11), as expected in the laboratory of an academic
hospital. However, in 14% of the cases we were able to provide
identification only to the genus level. Viridans streptococci
constituted 61% of these cases. Mainly the differentiation of
Streptococcus mitis, Streptococcus oralis, and Streptococcus
pneumoniae proved to be problematic. This is a well-known
problem when performing gene sequencing (1), but it also
illustrates a flaw in the use of the GenBank database. The
following case is exemplary. Gram-positive cocci in chains were
cultured from blood of a 56-year-old female. She was an on-
cology patient under treatment and was admitted to the hos-
pital with neutropenic fever and mucositis. Phenotypic testing
showed alpha-hemolytic streptococci of the S. mitis/oralis
group based on Gram stain morphology, negative catalase test,
optochin resistance, and negative esculin hydrolysis. The MIC
of penicillin was 4.0 g/ml. The organism was then evaluated
for bile solubility, which was negative. However, when se-
quence data of the isolate were compared to sequences depos-
ited in the GenBank database, S. pneumoniae was generated
with 99% similarity for the first best matches. This identifica-
tion was questioned because of the previous phenotypic re-
sults, the rarity of penicillin-resistant S. pneumoniae in The
Netherlands, and the clinical presentation.
In 4% of the cases, we were not able to obtain any identifi-
cation at first. This was due to mixed cultures and mixed or
ambiguous sequences but also due to alignments with low
percent identities and matching to ill-characterized strains.
The latter are additional flaws which are illustrated further
by the following case. An anaerobic gram-negative rod was
cultured from the blood of a 61-year-old male patient admitted
to the intensive care unit. Phenotypically, the bacterium was
identified as belonging to the Bacteroides fragilis group. Anal-
ysis of the sequence data by GenBank yielded at least 100
matches, with uncultured partially sequenced microorganisms
as the best matches. So, it was not possible to identify this
isolate by use of the GenBank database. However, when we
performed pairwise alignment with the sequences of the ref-
erence strain of B. fragilis, we obtained a perfect match. Align-
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ment with the sequences of the other members of the B. fragilis
group resulted in much lower percent identities and bit scores.
For now, the costs and quality of databases are major ob-
stacles to implementation of 16S rRNA gene sequencing in the
routine clinical microbiology laboratory. Use of public data-
bases is an affordable option, but one has to be aware of their
imperfections in terms of inaccurate identifications (2, 6, 9).
Also, the lack of stringent interpretation criteria is an obstacle.
In this context, the information obtained from phenotypic
methods remains important. Nevertheless, more and more
complete genome sequences of reference strains are becoming
available, as is the case with data on inter- and intraspecies
variability of different genera. We hope that this will improve
the quality of databases and lead to clearer interpretation
criteria in the future. This will guarantee the usefulness of 16S
rRNA gene sequencing and hence its implementation in daily
clinical laboratory practice.
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